About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Iscar for Supplemental Care in Stage IV Lung Cancer

NCT00079794·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

National Center for Complementary and Integrative Health (NCCIH)

See Brief Summary

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Stage IV NSCLC patients who receive standard chemotherapy

You may not be if

Known allergy to Viscum Album L.
Concomitant use of other mistletoe products
Concomitant use of mushroom glucan and proteoglycan extracts
Concomitant use of thymus extract products
Inability to self-report quality of life utilizing assessment tools
Ongoing steroid or ACTH therapy
Co-morbid immunocompromised state
Pregnancy
Participation in other clinical trials

The record

StatusCompleted

PhasePhase 2

Taking part36

StartedSep 2001

UpdatedJan 25, 2008

Conditions

Where1

Thomas Jefferson University
Philadelphia, Pennsylvania, United States

Clareo Health | Iscar for Supplemental Care in Stage IV Lung Cancer